Assay Performance Characteristics*

Platform

Assay chemistry

Procleix Panther system

Quantitative Parvo B19, qualitative HAV, transcription-mediated amplification (TMA)

Indication

Procleix Panther system

Blood screening, source plasma

Collection tube

Procleix Panther system

Serum or plasma from EDTA, ACD, heparin, or sodium citrate anti-coagulated samples

Pool sizes

Procleix Panther system

ID-NAT, 4, 8, 16, 48, 96, 256, 512

Assay kit size

Procleix Panther system

1000 tests

Detected virus

Procleix Panther system

Parvovirus B19 (genotypes 1, 2, and 3a)
HAV (genotypes I, II, and III)

Platform Procleix Panther system

Assay chemistry

Quantitative Parvo B19, qualitative HAV, transcription-mediated amplification (TMA)

Indication

Blood screening, source plasma

Collection tube

Serum or plasma from EDTA, ACD, heparin, or sodium citrate anti-coagulated samples

Pool sizes

ID-NAT, 4, 8, 16, 48, 96, 256, 512

Assay kit size

1000 tests

Detected virus

Parvovirus B19 (genotypes 1, 2, and 3a)
HAV (genotypes I, II, and III)

Accuracy & Precision Parvovirus B19 Quantitation on Procleix Panther System

B19 (IU/mL)

100,000

N (number of replicates tested)

54

Input and Observed log (IU/mL)

5.00 | 5.12

% Accuracy

102.5

Mean log difference (IU/mL)

0.12

Standard deviation (%CV)

0.13 (2.6%)

30,000

N (number of replicates tested)

54

Input and Observed log (IU/mL)

4.48 | 4.55

% Accuracy

101.5

Mean log difference (IU/mL)

0.07

Standard deviation (%CV)

0.15 (3.3%)

10,000

N (number of replicates tested)

54

Input and Observed log (IU/mL)

4.00 | 3.94

% Accuracy

98.6

Mean log difference (IU/mL)

-0.06

Standard deviation (%CV)

0.10 (2.5%)

3000

N (number of replicates tested)

59

Input and Observed log (IU/mL)

3.48 | 3.43

% Accuracy

98.5

Mean log difference (IU/mL)

-0.05

Standard deviation (%CV)

0.11 (3.2%)

1000

N (number of replicates tested)

60

Input and Observed log (IU/mL)

3.00 | 3.00

% Accuracy

99.9

Mean log difference (IU/mL)

0.00

Standard deviation (%CV)

0.20 (6.6%)

500

N (number of replicates tested)

189

Input and Observed log (IU/mL)

2.70 | 2.69

% Accuracy

99.7

Mean log difference (IU/mL)

-0.01

Standard deviation (%CV)

0.20 (7.3%)

B19 (IU/mL) N (number of replicates tested) Input and Observed log (IU/mL) % Accuracy Mean log difference (IU/mL) Standard deviation (%CV)

100,000

54

5.00 | 5.12

102.5

0.12

0.13 (2.6%)

30,000

54

4.48 | 4.55

101.5

0.07

0.15 (3.3%)

10,000

54

4.00 | 3.94

98.6

-0.06

0.10 (2.5%)

3000

59

3.48 | 3.43

98.5

-0.05

0.11 (3.2%)

1000

60

3.00 | 3.00

99.9

0.00

0.20 (6.6%)

500

189

2.70 | 2.69

99.7

-0.01

0.20 (7.3%)

Specificity of the Procleix Parvo/HAV Assay

Number of specimens tested

2010

HAV 95% (95% CI)

100%
(99.81‐100.00%)

B19 1000 IU/mL cutoff (95% CI)

100%
(99.81‐100.00%)

B19 500 IU/mL cutoff (95% CI)

99.90%
(99.64‐99.97%)

References:

* Procleix Parvo/HAV assay on the Procleix Panther system CE marked package insert, AW-12749-001 Rev. 007

Number of specimens tested HAV 95% (95% CI) B19 1000 IU/mL cutoff (95% CI) B19 500 IU/mL cutoff (95% CI)

2010

100%
(99.81‐100.00%)

100%
(99.81‐100.00%)

99.90%
(99.64‐99.97%)

Explore other Procleix Assays

Expand your blood screening with a comprehensive NAT assay portfolio.